![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
U.S. Population Benefits of HIV Preexposure Prophylaxis for Injection Drug Users
|
|
|
U.S. Population Benefits of HIV Preexposure Prophylaxis for Injection Drug Users
Reported by Jules Levin
CROI 2025 Feb 23-26, Seattle, WA
Cora Bernard1, Margaret Brandeau1, Eran Bendavid1, Christopher Weyant1, Jeremy Goldhaber-Fiebert1, Douglas K. Owens2, Keith Humphreys2, Mark Holodniy2
1 Stanford University, Stanford, California, United States;2 VA Palo Alto Health Care System, Palo Alto, California, United States
![CROI1.gif](../images/033015/033015-7/CROI1.gif)
![CROI2.gif](../images/033015/033015-7/CROI2.gif)
![CROI3.gif](../images/033015/033015-7/CROI3.gif)
![CROI4.gif](../images/033015/033015-7/CROI4.gif)
![CROI5.gif](../images/033015/033015-7/CROI5.gif)
![CROI6.gif](../images/033015/033015-7/CROI6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|